LOLI1 and hepatocellular carcinoma: The ability of ExInAtor2 to identify cancer lncRNAs was demonstrated by extensive functional studies, including for two lncRNAs, LOHAN1 (head and neck cancer) and LOLI1 (hepatocellular carcinoma).